FDA Morale Improvement Will Be A Priority, Von Eschenbach Testifies
This article was originally published in The Gray Sheet
Executive Summary
Acting FDA Commissioner Andrew von Eschenbach stressed his commitment to improving agency morale during his confirmation hearing